Eli Lilly’s new drug may reduce risk of complications for diabetes patients

(WISH Photo/Brett Bensley)

INDIANAPOLIS (WISH) – Eli Lilly said they have created a new diabetes drug that may reduce the risk of complications that kill many diabetes patients.

Eli Lilly and partner Boehringer Ingelheim conducted a three year study with nearly 7,000 patients.

Eli Lilly said in the Jardiance study, each patient was taking multiple standard medicines for diabetics to help control blood pressure, blood sugar and cholesterol levels. They said half were given Jardiance pills and the other half “dummy pills.”

They said their three year study showed those who took the drug delayed the time until they died of cardiovascular disease or suffered a heart attack or stroke.

They said while insulin and some medications help control blood sugar levels and sometimes weight, none have been shown to reduce cardiovascular complications.

Eli Lilly and Boehringer Ingelheim said they plan to release in detail their findings at a diabetes conference in Europe on Sept.17.

WISHTV.com provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Commenters who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others and keep the conversation on topic and civil. If you see an inappropriate comment, please flag it for our moderators to review.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s